Stay updated with breaking news from Nasdaq Pdsb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PDS Biotechnology Co. (NASDAQ:PDSB – Get Free Report) shares were down 8.8% on Friday . The stock traded as low as $2.59 and last traded at $2.65. Approximately 881,240 shares were traded during trading, a decline of 0% from the average daily volume of 884,327 shares. The stock had previously closed at $2.90. Wall Street […]
PDS Biotechnology (NASDAQ:PDSB – Free Report) had its price objective cut by Oppenheimer from $23.00 to $20.00 in a research report released on Wednesday morning, Benzinga reports. They currently have an outperform rating on the stock. A number of other equities analysts also recently issued reports on PDSB. B. Riley reaffirmed a buy rating on […]
StockNews.com started coverage on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a report issued on Thursday morning. The brokerage issued a sell rating on the stock. Separately, HC Wainwright reissued a buy rating and set a $21.00 target price on shares of PDS Biotechnology in a research note on Wednesday, September 27th. View […]
PDS0202 (Infectimune® + COBRA influenza antigens) vaccination also prevented illness/weight loss Vaccine protected against replication of the virus in the...
HC Wainwright restated their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a research note released on Monday morning, Benzinga reports. The brokerage currently has a $21.00 target price on the stock. HC Wainwright also issued estimates for PDS Biotechnology’s Q3 2023 earnings at ($0.45) EPS, Q4 2023 earnings at ($0.48) […]